Genomma Lab Internacional (GNMLF) Expected to Announce Earnings on Wednesday

Genomma Lab Internacional (OTCMKTS:GNMLF – Get Free Report) is expected to announce its results after the market closes on Wednesday, October 21st. Analysts expect the company to post earnings of $0.0210 per share and revenue of $240.97 million for the quarter.

Genomma Lab Internacional Price Performance

Shares of OTCMKTS:GNMLF opened at $0.72 on Tuesday. The company’s 50 day simple moving average is $0.77 and its 200 day simple moving average is $0.89. Genomma Lab Internacional has a 1 year low of $0.69 and a 1 year high of $1.08.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group began coverage on Genomma Lab Internacional in a research note on Sunday, July 19th. They set a “hold” rating for the company. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat, Genomma Lab Internacional has a consensus rating of “Hold”.

Read Our Latest Analysis on Genomma Lab Internacional

Genomma Lab Internacional Company Profile

(Get Free Report)

Genomma Lab Internacional, SAB. de C.V. (OTCMKTS: GNMLF) is a Mexico-based consumer healthcare and personal care company. It develops, markets and distributes over-the-counter medicines, medical devices, cosmetics and hygiene products, primarily through retail pharmacies, supermarkets and other consumer channels.

The company’s portfolio includes products for areas such as pain relief, respiratory health, gastrointestinal care, dermatology, hair care and skin care. Its recognized brands include Asepxia, Cicatricure, Goicoechea, Tío Nacho, Silka and Next, although product availability varies by market.

Genomma Lab was established in Mexico in 1996 and has expanded its operations across Latin America, with a presence that has included markets such as Argentina, Brazil, Chile, Colombia, Ecuador and Peru, as well as the United States.

Read More

Receive News & Ratings for Genomma Lab Internacional Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomma Lab Internacional and related companies with MarketBeat.com's FREE daily email newsletter.